Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development

Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 spread globally and creates an alarming situation. Following the SARS-CoV-2 paradigm, therapeutic efficacy is achieved via repurposing several antiviral, antibacterial, and antimalarial drugs. In...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kabeer Haneef, Rabia Saleem, Muhammad Saleem Iqbal Khan, Olawale Samuel Adeyinka, Sadeeq Banday, Muhammad Umer Asghar, Zia Ur Rahman, Zainab Fatima
Formato:	article
Lenguaje:	EN
Publicado:	Open Exploration Publishing Inc. 2021
Materias:	severe acute respiratory syndrome coronavirus 2 humoral immunity b cell receptor vaccine production adaptive immunity antibody pathogenesis cytokine responses non-structural protein Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/384630a1f78d4c3098b31044bc0772de
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development

Ejemplares similares